Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zoetendal, E. G., von Wright, A., Vilpponen-Salmela, T., Ben-Amor, K., Akkermans, A. D. L., & de Vos, W. M. (2002). Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Applied and Environmental Microbiology, 68(7), 3401–3407.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: the small intestine (28-yr-old female - CCUG) and clinical sources (trachea, crebrospinal fluid, blood - CCUG)
DNA G+C(%): 66.2
|
High T(℃): 41(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amoxicillin: R(25; disc)
Augmentin: R(MIC50): >64, MIC90: >64, RNG: (1->64)
ampicillin: R(10; disc)
aztreonam: R(30; disc)
penicillin: R(25; disc)
piperacillin: S(100; disc)
tica-clav: R(MIC50): >64, MIC90: >64, RNG: (2->64)
imipenem: S(MIC50): 1, MIC90: 2, RNG: (≤0.06-2)
meropenem: R(10; disc)
|
cefaclor: S(30; disc)
cefazolin: S(30; disc)
cefepime: Var(MIC50): 2, MIC90: 4, RNG: (1-4)
cefmetazole: S(30; disc)
cefoperazone: S(75; disc)
cefotaxime: S(30; disc)
cefotetan: R(MIC50): >64, MIC90: >64, RNG: (8->64)
ceftazidime: R(MIC50): 8, MIC90: 16, RNG: (2-16)
moxalactam: R(30; disc)
|
amikacin: R(30; disc)
gentamicin: R(10; disc)
|
erythromycin: R(15; disc)
clarithromycin: R(15; disc)
roxithromycin: R(15; disc)
|
ciprofloxacin: S(MIC50): 0.13, MIC90: 0.25, RNG: (≤0.06-0.25)
levofloxacin: S(5; disc)
norfloxacin: S(10; disc)
ofloxacin: S(5; disc)
sparfloxacin: S(5; disc)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: S(10; disc)
minocycline: S(30; disc)
tetracycline: S(30; disc)
|
|
|
trimethoprim: S(5; disc)
SXT: S(25; disc)
|
polymyxin_B: R(300; disc)
|